Join our FREE personalized newsletter for news, trends, and insights that matter to everyone in America

Newsletter
New

Apda Advocacy In Action: Why Medicare Payment Policy Matters

Card image cap

Medicare Payment Policy Can Affect People with Parkinson’s Access to Care

When most people hear the phrase “Medicare payment policy,” their eyes glaze over. It sounds technical, bureaucratic, and far removed from daily life. But for people living with Parkinson’s disease (PD) and other chronic conditions, Medicare payment policy shapes whether care is available, affordable, coordinated, and timely. Additionally, Medicare payment policy doesn’t just affect the 65+ population — it also informs private commercial payer policy by setting baseline benchmarks for pricing and coverage determinations that impact those under 65.

That is why APDA actively engages when the Centers for Medicare & Medicaid Services (CMS) proposes changes to Medicare rules. APDA’s advocacy is grounded in a simple belief: people living with Parkinson’s disease, their care partners, and their families deserve timely access to high-quality, coordinated, person-centered care. These proposals may look like updates to billing codes or formulas, but they can affect whether a person can see a specialist, receive therapy, avoid unnecessary delays, or manage symptoms before they become a crisis.

APDA works to support everyone impacted by Parkinson’s through education, services, research, community programs, and public policy advocacy. Medicare payment policy is one of the places where that mission becomes concrete: it is where patient needs, clinical realities, and federal decision-making meet.

Medicare payment policy is about access

Medicare does not just decide whether something is covered. It also decides how services are paid for, who can provide them, what paperwork is required, and whether patients face out-of-pocket costs. Those choices can make the difference between a care model that works in real life and one that looks good only on paper.

For Parkinson’s disease, this matters because care is not a one-time event. People often need ongoing medication management, rehabilitation, fall prevention, speech and occupational therapy, caregiver education, mental health support, and coordination among primary care providers, neurologists, movement disorder specialists, pharmacists, and community-based supports.

Small Medicare policy changes can create big practical barriers

When certain policy changes are made, even if they seem small, they can create big issues for people with PD.

  • Remote monitoring. Tools that help clinicians track mobility, symptoms, adherence, and therapy needs between office visits can be especially useful for people whose symptoms fluctuate or progress over time. But if Medicare limits who can support those services too narrowly, smaller practices, rural providers, or specialty clinics may struggle to offer them.
  • Shared medical appointments. Group-based visits can give people with Parkinson’s disease more time for education, peer support, caregiver involvement, and practical strategies for managing day-to-day symptoms – and are gaining in popularity. Payment policy determines whether innovative care models like these can be sustained and expanded.

Check out this special message from APDA’s Chief Public Policy Officer, Anne Hubbard, about the importance of Medicare payment policy and why it matters.


Administrative rules can delay needed treatment

Prior authorization is a good example of a policy that may sound harmless but can have real consequences. CMS has proposed expanding prior authorization requirements for botulinum toxin (Botox) injection services. These injections can be medically necessary for people with Parkinson’s disease who experience cervical dystonia, spasticity, blepharospasm, sialorrhea, and other neuromuscular symptoms.

When treatment is delayed, symptoms can return or worsen. A postponed injection can mean more pain, reduced function, greater difficulty swallowing or speaking, increased caregiving needs, and higher risk of avoidable complications.

APDA’s concern is simple: Medicare should not add new barriers unless there is clear evidence that the policy will reduce inappropriate care without harming access for people with legitimate medical needs.

Payment incentives affect how people experience care

Payment rules can also influence whether care is coordinated or fragmented. If Medicare reduces payment when a person receives a routine neurology visit and also needed botulinum toxin injection on the same day, financially stressed clinics serving rural populations may have to split those services into separate visits, which is not ideal for the patient, or in some cases the clinics may be forced to close their doors because they cannot sustain the reduction in revenue to offset their operating costs. For someone with Parkinson’s disease who has mobility challenges or lives far from a specialist, this impacts access to care and could mean another day of travel, another caregiver arrangement, and another obstacle to care.

Good payment policy should support the way people actually receive care: coordinated, convenient, clinically appropriate, and centered on the whole person.

Affordability is part of access

Even when Medicare covers a service, cost-sharing can prevent people from using it. Reducing or eliminating out-of-pocket costs for certain Medicare Part B services could help people with PD obtain medically necessary visits, rehabilitation, care management, and other supports that help maintain independence and quality of life.

Advocacy helps translate lived experience into better policy

Federal agencies need to hear how proposed rules will affect real people. APDA brings the voice of the Parkinson’s community into those decisions by explaining why utilization data alone does not tell the whole story, why delays matter, why rural and small-practice access matters, and why treatment for Parkinson’s disease requires more than isolated office visits.

APDA’s comment letters (Medicare Physician Fee Schedule letter and Hospital Outpatient Prospective Payment System letter) in response to these proposed policies help make sure people living with Parkinson’s disease are visible in decisions that could otherwise be made in the vacuum of Medicare payment policy without consideration for the people living every day with this disease.

This is APDA advocacy in action. Medicare payment policy may not sound like a kitchen-table issue, but it is. It shapes whether a person can get timely symptom treatment, whether a caregiver has support, whether a clinician can coordinate care effectively, and whether innovative approaches like remote monitoring and shared medical appointments can reach the people who need them. We are dedicated to making sure the PD community has a voice in these decisions that affect them so greatly.

How the APDA community can help

If you’re wondering what YOU can do to help make a difference about Medicare policy and help push for changes that will truly benefit the PD community, we encourage you to:

  • Stay informed when Medicare proposes changes that could affect access to specialists, therapies, medications, symptom-management services, or coordinated care.
  • Share personal experiences with APDA so our advocacy efforts are sure to reflect the real-world impact of Medicare policy on people living with Parkinson’s disease and their care partners. You can email us at advocacy@apdaparkinson.org.
  • Help policymakers understand that Parkinson’s care requires timely access to neurologists, movement disorder specialists, rehabilitation professionals, mental health providers, pharmacists, caregivers, and community supports. Visit our Advocacy Action Center for easy ways to send messages to your local representatives.
  • Support APDA’s work to advance public policy solutions that improve lives today while moving us toward better treatments and, ultimately, a world without Parkinson’s disease.
  • Sign up for APDA Advocacy Action Alerts so we can keep you posted on opportunities to raise your voice.

Tips & Takeaways

  • Medicare payment policy shapes whether care is available, affordable, coordinated, and timely. It also informs private commercial payer policy by setting baseline benchmarks for pricing and coverage determinations that impact those under 65.
  • Even seemingly small policy changes can have a big, potentially negative impact on people with PD.
  • APDA is pushing for Medicare payment policies that are fair and benefit the PD community’s true needs.
  • Contact the APDA Public Policy & Advocacy team at advocacy@apdparkinson.org
  • Sign up for APDA Advocacy Action Alerts today!

The post APDA Advocacy in Action: Why Medicare Payment Policy Matters appeared first on American Parkinson Disease Association.